Genomics USA
Tucson, Arizona, United States
About Genomics USA
Genomics USA, Inc. develops and fabricates micro array technologies to bypass DNA purification and quantitation by allowing human leukocyte antigen (HLA) typing directly from raw blood (rehydrated) dried blood spots on Guthrie cards and from raw buccalswabs. It offers HLA Chip technology based on HLA typing for tissue transplantation and stem cell therapeutics, as well as based on HLA analysis for vaccine development, personalized vaccine delivery, personalized treatment for autoimmune diseases, and personalized treatment of microbial infection. Genomics USA was incorporated in 2004 and is based in Inverness, Illinois.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $837.4K
- Last round: Debt Financing (Jun 2013)
- Website: gmsbiotech.com
- Phone: 8473591053
Industries & Categories
Biotechnology, Developer Platform, Genetics
Canonical: https://fsome.com/organization/genomics-usa-2478617 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.